Literature DB >> 10552239

Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images.

M Rovaris1, F Barkhof, S Bastianello, C Gasperini, N Tubridy, T A Yousry, M P Sormani, B Viti, D H Miller, M Filippi.   

Abstract

Previous studies have addressed the question of the precision in assessing multiple sclerosis (MS) activity by counting enhancing lesions on gadolinium enhanced brain magnetic resonance imaging (MRI). However, counting the active lesions on serial unenhanced MRI obtained by various pulse sequences has not been yet considered. We compared the interobserver levels of agreement in reporting active MS lesions on serial enhanced and unenhanced MRI to assess whether the use of various unenhanced techniques may change the degree of interobserver measurement reproducibility. Dual-echo conventional spin echo (CSE), dual-echo fast spin echo (FSE), fast fluid-attenuated inversion recovery (FLAIR) and Gd-enhanced T1-weighted brain MRI were obtained from five MS patients at baseline and monthly for 2 months. Six experienced observers independently identified and counted active MS lesions on the two follow-up MRI scans. Active lesions were considered to be all the enhancing lesions and any new or enlarging lesion on enhanced and unenhanced scans. Interobserver levels of agreement were calculated by weighted kappa values. Very good agreement was reached only for counting total and new Gd-enhancing lesions. Good agreement was achieved for counting new lesions on the three unenhanced techniques, whereas the agreement for counting enlarging lesions was poor with all the MRI techniques. The level of agreement was significantly heterogeneous for various MRI techniques but not for various lesion sites. These results confirm that counting enhancing lesions is the most reliable method for assessing MS activity, but the use of any of the available unenhanced MRI techniques did not result in different levels of interobserver agreement when reporting new and enlarging MS lesions on serial scans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10552239     DOI: 10.1007/s004150050483

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  5 in total

Review 1.  MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.

Authors:  Frederik Barkhof; Jack H Simon; Franz Fazekas; Marco Rovaris; Ludwig Kappos; Nicola de Stefano; Chris H Polman; John Petkau; Ernst W Radue; Maria P Sormani; David K Li; Paul O'Connor; Xavier Montalban; David H Miller; Massimo Filippi
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

2.  Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis.

Authors:  Tijmen Korteweg; Bernard M J Uitdehaag; Dirk L Knol; Robin H M Smithuis; Paul R Algra; Cees de Vries; Peter A Poppe; Jan-Hein T M van Waesberghe; Elisabeth Bergers; Geert J Lycklama à Nijeholt; Chris H Polman; Frederik Barkhof
Journal:  Eur Radiol       Date:  2006-05-18       Impact factor: 5.315

3.  Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis.

Authors:  Marco Rovaris; Giancarlo Comi; David Ladkani; Jerry S Wolinsky; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

4.  Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.

Authors:  Josa M Frischer; Stephen D Weigand; Yong Guo; Nilufer Kale; Joseph E Parisi; Istvan Pirko; Jay Mandrekar; Stephan Bramow; Imke Metz; Wolfgang Brück; Hans Lassmann; Claudia F Lucchinetti
Journal:  Ann Neurol       Date:  2015-08-24       Impact factor: 10.422

5.  Automated segmentation of changes in FLAIR-hyperintense white matter lesions in multiple sclerosis on serial magnetic resonance imaging.

Authors:  Paul Schmidt; Viola Pongratz; Pascal Küster; Dominik Meier; Jens Wuerfel; Carsten Lukas; Barbara Bellenberg; Frauke Zipp; Sergiu Groppa; Philipp G Sämann; Frank Weber; Christian Gaser; Thomas Franke; Matthias Bussas; Jan Kirschke; Claus Zimmer; Bernhard Hemmer; Mark Mühlau
Journal:  Neuroimage Clin       Date:  2019-05-02       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.